Aquestive Therapeutics, Inc. · NASDAQ:AQST
Davis Matthew W. had 5,303 Aquestive Therapeutics, Inc. shares withheld for tax (Form 4)
Traded Nov 10, 2026 · Filed Nov 12, 2026
On Nov 10, 2026, Davis Matthew W. (Chief Development Officer) had 5,303 Aquestive Therapeutics, Inc. shares withheld for tax at US$3.52 for US$18,667, leaving 94,697 shares. Filed Nov 12, 2026 (Form 4).
- Withheld for tax
- 5,303 shares
- Price
- US$3.52
- Value
- US$18,667
- Holding after
- 94,697 shares
- Trading plan
- No
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Common Stock | Shares withheld for tax | 5,303 | US$3.52 | 94,697 | Direct |
Source
Download original · View original at SEC
Related
- Aquestive Therapeutics, Inc.
- Davis Matthew W.
- Aquestive Therapeutics, Inc. shareholders
- Form 4 · Davis Matthew W. · Nov 16, 2026
- Form 4 · Daly Richard J · Nov 12, 2026
- Form 4 · Cochran John · Oct 23, 2026
- Form 4 · Barber Daniel · Oct 16, 2026
- Schedule 13G · Bass Edward P · Oct 7, 2026
- Schedule 13G/A · Bratton Douglas K · Oct 7, 2026